Difference between revisions of "Part:BBa K4477013:Design"
(→Design Notes) |
(→Source) |
||
(4 intermediate revisions by the same user not shown) | |||
Line 7: | Line 7: | ||
===Design Notes=== | ===Design Notes=== | ||
− | Amino acid sequences were reverse transcribed and codon optimized for expression in <em>E. coli | + | Amino acid sequences were reverse transcribed and codon optimized for expression in <em>E. coli</em> B (the parent strain of the SHuffle we're using). In addition, further codon optimization was used to remove illegal restriction sites from the construct. |
− | His tag and TEV cleavage sites were included downstream of the start codon but upstream of the antibody coding sequence. The His tag ensured the | + | His tag and TEV cleavage sites were included downstream of the start codon but upstream of the antibody coding sequence. The His tag ensured that the McPC603 scFv could be purified out of a total protein solution using immobilized metal ion affinity chromatography (IMAC), and the TEV cleavage site ensured that TEV could be used to cleave off the His tag once it was no longer needed. |
− | A two-way terminator was used so that any genes in the vector in which this insert will be | + | A two-way terminator was used so that any genes in the vector in which this insert will be cloned that happen to be on the strand opposite to the strand encoding the insert will not be read backward into the insert and interfere with transcription of our antibody of interest. |
For detailed annotations of the sequence, see Team Virginia 2022's Benchling folder here: https://benchling.com/mrkhoury/f_/YR4zZSUb-virginia-igem-2022-dna-constructs/ | For detailed annotations of the sequence, see Team Virginia 2022's Benchling folder here: https://benchling.com/mrkhoury/f_/YR4zZSUb-virginia-igem-2022-dna-constructs/ | ||
===Source=== | ===Source=== | ||
− | + | Sequences acquired from: | |
1. https://www.sciencedirect.com/science/article/pii/S0769262585800581 <br> | 1. https://www.sciencedirect.com/science/article/pii/S0769262585800581 <br> | ||
2. https://pubmed.ncbi.nlm.nih.gov/14644097/ | 2. https://pubmed.ncbi.nlm.nih.gov/14644097/ | ||
+ | |||
+ | Once the part was designed, it was sent out for synthesis from IDT. | ||
===References=== | ===References=== | ||
3. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3312285/ <br> | 3. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3312285/ <br> | ||
4. https://www.pnas.org/doi/epdf/10.1073/pnas.71.11.4298 | 4. https://www.pnas.org/doi/epdf/10.1073/pnas.71.11.4298 |
Latest revision as of 15:37, 12 October 2022
McPC603 anti-oxLDL scFv - complete expression cassette
- 10COMPATIBLE WITH RFC[10]
- 12COMPATIBLE WITH RFC[12]
- 21INCOMPATIBLE WITH RFC[21]Illegal BamHI site found at 446
- 23COMPATIBLE WITH RFC[23]
- 25INCOMPATIBLE WITH RFC[25]Illegal AgeI site found at 752
- 1000COMPATIBLE WITH RFC[1000]
Design Notes
Amino acid sequences were reverse transcribed and codon optimized for expression in E. coli B (the parent strain of the SHuffle we're using). In addition, further codon optimization was used to remove illegal restriction sites from the construct.
His tag and TEV cleavage sites were included downstream of the start codon but upstream of the antibody coding sequence. The His tag ensured that the McPC603 scFv could be purified out of a total protein solution using immobilized metal ion affinity chromatography (IMAC), and the TEV cleavage site ensured that TEV could be used to cleave off the His tag once it was no longer needed.
A two-way terminator was used so that any genes in the vector in which this insert will be cloned that happen to be on the strand opposite to the strand encoding the insert will not be read backward into the insert and interfere with transcription of our antibody of interest.
For detailed annotations of the sequence, see Team Virginia 2022's Benchling folder here: https://benchling.com/mrkhoury/f_/YR4zZSUb-virginia-igem-2022-dna-constructs/
Source
Sequences acquired from:
1. https://www.sciencedirect.com/science/article/pii/S0769262585800581
2. https://pubmed.ncbi.nlm.nih.gov/14644097/
Once the part was designed, it was sent out for synthesis from IDT.
References
3. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3312285/
4. https://www.pnas.org/doi/epdf/10.1073/pnas.71.11.4298